Clonal evolution including 14q32/<i>IGH</i>translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients
Francesco Cavazzini(Arcispedale Sant'Anna), Gian Matteo Rigolin, Elisa Tammiso(Arcispedale Sant'Anna), Elena Saccenti(University of Ferrara), Francesca Cibien(University of Ferrara), Olga Sofritti(University of Ferrara), Lara Rizzotto, Antonio Cuneo(Arcispedale Sant'Anna), Giulia Daghia(University of Ferrara), Maria Ciccone(Arcispedale Sant'Anna), Sara Martinelli(University of Ferrara), Melissa Dabusti(University of Ferrara), Abbas Awad Elkareem(University of Ferrara), Antonella Bardi(University of Ferrara)
Cited by 19
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|215
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
|Blood|2019|215
Absolute quantification of cell-free microRNAs in cancer patients
|Oncotarget|2015|125